Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Uttley, L. orcid.org/0000-0003-4603-9069, Whyte, S., Gomersall, T. et al. (4 more authors) (2017) Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics , 35 (7). pp. 717-726. ISSN 1170-7690

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Springer International Publishing Switzerland 2016. This is an author produced version of a paper subsequently published in PharmacoEconomics. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published (online): 10 December 2016
  • Published: July 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 14 Dec 2016 10:53
Last Modified: 29 Jan 2018 11:49
Published Version: https://doi.org/10.1007/s40273-016-0481-1
Status: Published
Publisher: Springer Verlag
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-016-0481-1
Related URLs:

Share / Export

Statistics